Dual Functioned Pegylated Phospholipid Micelles Containing Cationic Antimicrobial Decapeptide for Treating Sepsis
- Authors
- Lee, Wonhwa; Park, Eun Ji; Min, Gahee; Choi, Joonhyeok; Na, Dong Hee; Bae, Jong-Sup
- Issue Date
- Sep-2017
- Publisher
- IVYSPRING INT PUBL
- Keywords
- sepsis; KSLW; PEGylation; DSPE; occluding
- Citation
- THERANOSTICS, v.7, no.15, pp 3759 - 3767
- Pages
- 9
- Journal Title
- THERANOSTICS
- Volume
- 7
- Number
- 15
- Start Page
- 3759
- End Page
- 3767
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6269
- DOI
- 10.7150/thno.20734
- ISSN
- 1838-7640
- Abstract
- Despite intensive investigation of molecular mechanisms underlying the pathogenesis of sepsis, many aspects of sepsis remain unresolved; this hampers the development of appropriate therapeutics. In the present study, we developed a biologic nanomedicine containing a cationic antimicrobial decapeptide KSLW (KKVVFWVKFK), self-associated with biocompatible and biodegradable PEGylated phospholipid micelles (PLM), and analyzed its efficacy for treating sepsis. KSLW was modified with polyethylene glycol (PEG)-aldehyde or was conjugated with distearoylphosphatidylethanolamine (DSPE) -PEG-aldehyde. We compared the antibacterial and antiseptic effects of PEG-KSLW and PLM-KSLW with those of unmodified KSLW both in vitro and in vivo. We found that the PLM-KSLW improved the survival rate of sepsis mouse models without undesired immune responses, and inhibited lipopolysaccharide (LPS)-induced severe vascular inflammatory responses in human umbilical vein endothelial cells compared with unmodified KSLW or PEG-KSLW. Furthermore, PLM-KSLW dramatically reduced the bacterial count and inhibited bacterial growth. We also found a new role of PLM-KSLW in tightening vascular barrier integrity by binding to the glycine/tyrosine-rich domain of occludin (OCLN). Our results showed that PLM-KSLW had a more effective antiseptic effect than KSLW or PEG-KSLW, possibly because of its high affinity toward OCLN. Moreover, PLM-KSLW could be potentially used to treat severe vascular inflammatory diseases, including sepsis and septic shock.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6269)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.